Canada Life
GEN

Canada Life’s Genesis Healthcare, Inc. GEN Stock Holding History

Canada Life’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-65,846
Closed -$75K – 2579
2017
Q3 		$75K Hold
65,846
– – ﹤0.01% 2231
2017
Q2 		$114K Buy
+65,846
New +$140K ﹤0.01% 2077

Other funds holding GEN

CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Canada Life's GEN Position: Q4 2017 in Review

Canada Life sold out of Genesis Healthcare, Inc. (GEN) in Q4 2017, closing a stake of 65,846 shares — an estimated $75K sold.

Canada Life first reported a position in GEN in Q2 2017 and held it in 2 quarters. The position peaked at $114K in Q2 2017. 68 funds tracked by Wall St. Rank hold GEN as of Q4 2017.

  • Canada Life reported no remaining Genesis Healthcare, Inc. position as of Q4 2017 after selling out during the quarter.
  • Canada Life sold 65,846 Genesis Healthcare, Inc. shares in Q4 2017, an estimated $75K.
  • Canada Life first reported a position in Genesis Healthcare, Inc. in Q2 2017 and held it in 2 quarters.
  • Canada Life's Genesis Healthcare, Inc. position peaked at $114K in Q2 2017.
  • 68 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2017.

Based on Canada Life's 13F filing for Q4 2017, filed 9 Feb 2018.